Welcome to the e-CCO Library!

DOP013: A 104 week mucosal healing assessment of symptomatic small bowel Crohn’s disease
Year: 2016
Source: ECCO'16 DOP
Authors: Hall B.
anti-TNF, capsule endoscpy, Crohn's Disease, mucosal healing
Files: 1
DOP013: An IBD associated variant in PTPN2 promotes inflammatory responses but enhances the anti-inflammatory effect of spermidine
Year: 2018
Source: ECCO'18 Vienna
Authors: Butter Matthias
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP013: An IBD-associated variant in PTPN2 promotes inflammatory responses but enhances the anti-inflammatory effect of spermidine
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Butter*, N. Obialo, K. Bäbler, L. Van der Lely, S. Lang, C. Gottier, M. Scharl, M.R. Spalinger

Created: Thursday, 21 February 2019, 9:14 AM
DOP013: Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buisson A.*1,2, Messadeg L.3, Bouguen G.4, Goutorbe F.1,5, Reimund J.-M.6, Goutte M.1,2, Sautel C.7, Duron C.8, Scanzi J.1, Reymond M.1, Allimant C.1, Dapoigny M.1, Bommelaer G.1,2, Pereira B.9, Hordonneau C.3

Created: Wednesday, 20 February 2019, 10:36 AM
DOP013: Definition of therapeutic response criteria using MRI in Crohn’s Disease patients treated with anti-TNF therapy: A multicenter prospective study (the IRMA study)
Year: 2017
Source: ECCO'17 Barcelona
Authors: Buisson A.
Crohn's disease, Disease activity Indices, MRI, Adalimumab, Infliximab
Files: 1
DOP014: Impact of genetic variation on gene and protein expression in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Hart*, K. Hayden, E. Wadman, S. Bhagat, D. Jacobstein, C. Brodmerkel, J. Friedman, K. Li

Created: Thursday, 21 February 2019, 9:14 AM
DOP014: Impact of genetic variation on gene and protein expression in Crohn’s Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Hart Amy
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP014: Nutritional optimisation of pre-surgical Crohn’s disease patients with enteral nutrition significantly decreases length of stay and need for a stoma
Year: 2016
Source: ECCO'16 DOP
Authors: Patel K.
ileocecal resection, postoperative complications, preoperative management, enteral nutrition
Files: 1
DOP014: Nutritional optimisation of presurgical Crohns disease patients with enteral nutrition significantly decreases length of stay and need for a stoma
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. V. Patel*1, A. M. Sandall2, D. V. O’Hanlon3, A. A. Darakhshan4, A. B. Williams4, S. H. Anderson1, P. M. Irving1, M. C. Lomer5, J. D. Sanderson1

Created: Friday, 22 February 2019, 9:49 AM
DOP014: Transmural healing is better than mucosal healing in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Raimundo Fernandes S.*1, Vale Rodrigues R.2, Bernardo S.1, Cortez Pinto J.2, Rosa I.2, Correia L.1, Moura Santos P.3, Rita Gonçalves A.3, Valente A.3, Baldaia C.3, Pereira da Silva J.2, Dias Pereira A.2, Velosa J.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP014: Transmural healing is better than mucosal healing in Crohn's Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Raimundo Fernandes S.
Natural history, Colonoscopy, MRI
Files: 1
DOP015: Dysregulation of cell-type specific long ncRNA in the ileum of treatment naïve early onset Crohn Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Haberman Yael
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP015: Dysregulation of cell-type-specific long ncRNA in the ileum of treatment naïve early onset Crohn disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y. Haberman1,2*, M. BenShoshan1, A. Di Segni1, P.J. Dexheimer3, T. Braun1, B. Weiss1, C. Avivi1, I. Barshack1, Y. Anikster1, B. Aronow3, J.S. Hyams4, S. Kugathasan5, L.A. Denson3, The Crohn's & Colitis Foundation (CCF)-sponsored RISK study

Created: Thursday, 21 February 2019, 9:14 AM
DOP015: International differences in gastroenterologists' perspective on stopping therapy for patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Siegel C.A.*1, Thompson K.D.1, Walls D.2, Gollins J.3, Colombel J.-F.4, Louis E.5 on behalf of the BIOCYCLE Group5

Created: Wednesday, 20 February 2019, 10:36 AM
DOP015: International differences in gastroenterologists’ perspective on stopping therapy for patients with Crohn’s Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Siegel C.
Anti-TNF agents, Corticosteriods, Patient choice, Thiopurines (AZA / MP)
Files: 1
DOP015: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohns disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Decousus1, A.-L. Boucher2, J. Joubert1, M. Goutte2, 3, F. Goutorbe2, A. Dubois4, B. Pereira5, P. Dechelotte1, G. Bommelaer2, 3, A. Buisson*2, 3

Created: Friday, 22 February 2019, 9:49 AM
DOP015: Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn’s disease
Year: 2016
Source: ECCO'16 DOP
Authors: Buisson A.
Crohn's Disease, ileo caecal resection, post operative complications, histology
Files: 1
DOP016: Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Chaparro M.*1, Verreth A.2, Lobaton T.3, Gravito-Soares E.4, Julsgaard M.5, Savarino E.6, Magro F.7, Avni Biron I.8, Lόpez-Serrano P.9, Casanova M.1, Gompertz M.10, Vitor S.11, Arroyo M.12, Pugliese D.13, Zabana Y.14, Vicente R.15, Aguas M.16, Bar-Gil Shitrit A.17, Gutierrez A.18, Doherty G.19, Fernández-Salazar L.20, Martinez Cadilla J.21, Huguet J.22, O'Toole A.23, Stasi E.24, Manceñido Marcos N.25, Villoria A.26, Karmiris K.27, Rahier J.28, Rodriguez C.29, Diz-Lois Palomares M.30, Fiorino G.31, Benítez J.32, Principi M.33, Naftali T.34, Taxonera C.35, Mantzaris G.36, Sebkova L.37, Iade B.38, Lissner D.39, Ferrer Bradley I.40, Lόpez-San Román A.41, Marín-Jiménez I.42, Merino O.43, Sierra M.44, Van Domselaar M.45, Caprioli F.46, Guerra I.47, Peixe P.48, Piqueras M.49, Rodríguez-Lago I.50, Ber Y.51, Van Hoeve K.2, Torres P.3, Gravito-Soares E.4, Rudbeck-Thomsen D.5, Bartolo O.6, Peixoto A.7, Martín G.8, Pérez J.1, Garre A.1, Donday M.G.1, Martín de Carpi J.52, Gisbert J.P.1 Gastroenterology Units, on behalf of the TEDDY Study Group Investigators

Created: Wednesday, 20 February 2019, 10:36 AM
DOP016: Metagenomic analysis of intestinal mucosa revealed an IBD-specific shift in the eukaryotic gut virome composition at early stages of gut inflammation
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Ungaro1*, L. Massimino2, S. D'Alessio1, S. Danese1

Created: Thursday, 21 February 2019, 9:14 AM